Na+ CP type IXα Polyclonal Antibody

Rabbit Anti-Na+ CP type IXα Polyclonal Antibody

Product Specifications

Background

SCN9A encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in SCN9A have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder.

CAS Number

9007-83-4

Product Name Alternative

SCN9A; NENA; Sodium channel protein type 9 subunit alpha; Neuroendocrine sodium channel; hNE-Na; Peripheral sodium channel 1; PN1; Sodium channel protein type IX subunit alpha; Voltage-gated sodium channel subunit alpha Nav1.7

Gene ID

6335

Accession Number

Q15858

Reactivity

Human, Mouse, Rat

Immunogen

Synthesized peptide derived from the Internal region of human Na+ CP type IXα at AA range: 620-700

Clonality

Polyclonal

Tag

Sodium channel protein type 9 subunit alpha

Applications

WB, IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

220kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

Na+ CP type IXα Polyclonal Antibody detects endogenous levels of Na+ CP type IXα protein.

Observed Molecular Weight

220

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000; IHC 1:100-1:300; ELISA 1:40000; IF 1:50-200